Abeona therapeutics® closes sale of rare pediatric disease priority review voucher for $155 million

Cash resources totaled approximately $225 million as of june 30, 2025 cash resources totaled approximately $225 million as of june 30, 2025
ABEO Ratings Summary
ABEO Quant Ranking